BioSig Technologies, Inc. Revenue 2020–2024
BioSig Technologies, Inc. annual/quarterly revenue history and growth rate from 2020 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- BioSig Technologies, Inc. revenue for the quarter ending June 30, 2024 was 13000.
- BioSig Technologies, Inc. revenue for the twelve months ending June 30, 2024 was 28000, a 82.05% decrease year-over-year.
- BioSig Technologies, Inc. annual revenue for 2024 was 40000, a 122.22% increase from 2023.
- BioSig Technologies, Inc. annual revenue for 2023 was 18000, a 93.71% decrease from 2022.
- BioSig Technologies, Inc. annual revenue for 2022 was 286000, a 35.15% decrease from 2021.
- BioSig Technologies, Inc. annual revenue for 2021 was 441000.
BioSig Technologies, Inc. (STEX) — Frequently Asked Questions
BioSig Technologies, Inc. (STEX) is a publicly traded US company. It has a market capitalization of $13M. In fiscal 2024 it reported revenue of $40,000 and net income of -$10M. Explore STEX's stock price, financial statements, earnings history, margins and key ratios below.
What is BioSig Technologies, Inc.'s market cap?
BioSig Technologies, Inc. (STEX) has a market capitalization of $13M.
What is the STEX stock price?
STEX trades at $0.95 (+3.38% on the day).
How much revenue does BioSig Technologies, Inc. make?
BioSig Technologies, Inc. reported revenue of $40,000 in fiscal 2024.
Is STEX profitable?
In fiscal 2024, BioSig Technologies, Inc. reported net income of -$10M.